Efficacy of adjuvant aromatase inhibitor in hormone receptor-positive postmenopausal breast cancer patients according to the body mass index


Sendur M. A. N. , Aksoy S., Zengin N., Altundag K.

BRITISH JOURNAL OF CANCER, cilt.107, sa.11, ss.1815-1819, 2012 (SCI İndekslerine Giren Dergi) identifier identifier identifier

  • Cilt numarası: 107 Konu: 11
  • Basım Tarihi: 2012
  • Doi Numarası: 10.1038/bjc.2012.473
  • Dergi Adı: BRITISH JOURNAL OF CANCER
  • Sayfa Sayıları: ss.1815-1819

Özet

BACKGROUND: Increased adiposity may trigger signalling pathways that induce aromatase expression. As aromatase inhibitors exert their effects by blocking the aromatase enzyme, higher body mass index (BMI) can reduce the effect of aromatase inhibitors. Thus, we aimed to investigate retrospectively the effect of BMI on the efficacy of aromatase inhibitors in hormone receptor-positive postmenopausal patients with breast cancer.